123 related articles for article (PubMed ID: 35121847)
1. Validation and refinement of a RUNX1 mutation-associated gene expression signature in blast crisis chronic myeloid leukemia.
Lee KL; Ko TK; Saw NYL; Javed A; Hillmer AM; Chuah C; Krishnan V; Ong ST
Leukemia; 2022 Mar; 36(3):892-896. PubMed ID: 35121847
[No Abstract] [Full Text] [Related]
2. A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases.
Grossmann V; Kohlmann A; Zenger M; Schindela S; Eder C; Weissmann S; Schnittger S; Kern W; Müller MC; Hochhaus A; Haferlach T; Haferlach C
Leukemia; 2011 Mar; 25(3):557-60. PubMed ID: 21274004
[No Abstract] [Full Text] [Related]
3. RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses.
Adnan Awad S; Dufva O; Ianevski A; Ghimire B; Koski J; Maliniemi P; Thomson D; Schreiber A; Heckman CA; Koskenvesa P; Korhonen M; Porkka K; Branford S; Aittokallio T; Kankainen M; Mustjoki S
Leukemia; 2021 Apr; 35(4):1087-1099. PubMed ID: 32782381
[TBL] [Abstract][Full Text] [Related]
4. Functional features of RUNX1 mutants in acute transformation of chronic myeloid leukemia and their contribution to inducing murine full-blown leukemia.
Zhao LJ; Wang YY; Li G; Ma LY; Xiong SM; Weng XQ; Zhang WN; Wu B; Chen Z; Chen SJ
Blood; 2012 Mar; 119(12):2873-82. PubMed ID: 22318203
[TBL] [Abstract][Full Text] [Related]
5. Clonal evolution of AML1-ETO coexisting with BCR-ABL and additional chromosome abnormalities in a blastic transformation of chronic myeloid leukemia.
Ma CC; Chai Y; Chen HL; Wang X; Gao Y; Hu WL; Xiang X
J Int Med Res; 2020 May; 48(5):300060520919237. PubMed ID: 32366154
[TBL] [Abstract][Full Text] [Related]
6. RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance.
Roche-Lestienne C; Deluche L; Corm S; Tigaud I; Joha S; Philippe N; Geffroy S; Laï JL; Nicolini FE; Preudhomme C;
Blood; 2008 Apr; 111(7):3735-41. PubMed ID: 18202228
[TBL] [Abstract][Full Text] [Related]
7. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
[TBL] [Abstract][Full Text] [Related]
8. [Molecular mechanisms underlying leukemic transformation of myelodysplastic syndromes (MDS) and chronic myelogenous leukemia (CML)].
Kitamura T; Watanabe-Okochi N; Inoue D; Togami K; Uchida T; Kagiyama Y; Kawabata K; Chiba S; Harada Y; Harada H; Kitaura J; Nakahara F
Rinsho Ketsueki; 2012 Aug; 53(8):734-9. PubMed ID: 22975812
[No Abstract] [Full Text] [Related]
9. Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia.
Giustacchini A; Thongjuea S; Barkas N; Woll PS; Povinelli BJ; Booth CAG; Sopp P; Norfo R; Rodriguez-Meira A; Ashley N; Jamieson L; Vyas P; Anderson K; Segerstolpe Å; Qian H; Olsson-Strömberg U; Mustjoki S; Sandberg R; Jacobsen SEW; Mead AJ
Nat Med; 2017 Jun; 23(6):692-702. PubMed ID: 28504724
[TBL] [Abstract][Full Text] [Related]
10. Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cells.
Nakahara F; Kitaura J; Uchida T; Nishida C; Togami K; Inoue D; Matsukawa T; Kagiyama Y; Enomoto Y; Kawabata KC; Chen-Yi L; Komeno Y; Izawa K; Oki T; Nagae G; Harada Y; Harada H; Otsu M; Aburatani H; Heissig B; Hattori K; Kitamura T
Blood; 2014 Jun; 123(25):3932-42. PubMed ID: 24825862
[TBL] [Abstract][Full Text] [Related]
11. Cadherin-13 in primary and blast crisis chronic myeloid leukaemia: declining expression and negative correlation with the BCR/ABL fusion gene.
Mu HJ; Xie R; Shen YF; Jiang YQ; Zeng YJ
Br J Biomed Sci; 2009; 66(1):20-4. PubMed ID: 19348122
[TBL] [Abstract][Full Text] [Related]
12. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
13. Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression.
Gaiger A; Henn T; Hörth E; Geissler K; Mitterbauer G; Maier-Dobersberger T; Greinix H; Mannhalter C; Haas OA; Lechner K; Lion T
Blood; 1995 Sep; 86(6):2371-8. PubMed ID: 7662984
[TBL] [Abstract][Full Text] [Related]
14. A new case of chronic myeloid leukemia (CML) in myeloid blast crisis with an atypical (b3/a3) junction of the BCR/ABL gene.
Polák J; Zemanová Z; Michalová K; Klamová H; Cermák J; Haskovec C
Leukemia; 1998 Feb; 12(2):250. PubMed ID: 9519792
[No Abstract] [Full Text] [Related]
15. IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis.
Soverini S; Score J; Iacobucci I; Poerio A; Lonetti A; Gnani A; Colarossi S; Ferrari A; Castagnetti F; Rosti G; Cervantes F; Hochhaus A; Delledonne M; Ferrarini A; Sazzini M; Luiselli D; Baccarani M; Cross NC; Martinelli G
Leukemia; 2011 Jan; 25(1):178-81. PubMed ID: 20962862
[No Abstract] [Full Text] [Related]
16. Blast crisis of chronic myeloid leukemia with plasmacytoid dendritic cell phenotype associated with a rare fusion transcript, e13a3 BCR-ABL1.
Xu D; Claudiani S; Naresh K; Mucklow S; Neelakantan P; Yebra E; Apperley JF; Khorashad J; Milojkovic D
Leuk Lymphoma; 2019 Dec; 60(12):3090-3091. PubMed ID: 31184233
[No Abstract] [Full Text] [Related]
17. p53 gene mutation in the chronic phase was not detected in the myeloid crisis of a chronic myelocytic leukemia case.
Kurosawa M; Okabe M; Kunieda Y; Miyazaki T
Blood; 1994 May; 83(9):2750-2. PubMed ID: 8167355
[No Abstract] [Full Text] [Related]
18. Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia.
Miyazaki K; Yamasaki N; Oda H; Kuwata T; Kanno Y; Miyazaki M; Komeno Y; Kitaura J; Honda Z; Warming S; Jenkins NA; Copeland NG; Kitamura T; Nakamura T; Honda H
Blood; 2009 May; 113(19):4702-10. PubMed ID: 19234145
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations.
Xu L; Lu Y; Lai J; Yu W; Zhang Y; Jin Z; Xu Y; Chen J; Zha X; Chen S; Yang L; Li Y
Sci China Life Sci; 2015 Dec; 58(12):1276-81. PubMed ID: 26423566
[TBL] [Abstract][Full Text] [Related]
20. Rearrangement of the BCR/ABL and TCR-beta genes in lymph node blast crisis diagnosed of chronic myeloid leukemia.
Villegas A; González FA
Am J Hematol; 1994 Apr; 45(4):347. PubMed ID: 8178807
[No Abstract] [Full Text] [Related]
[Next] [New Search]
